Red Door Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Sell
6,264
-757
-11% -$99.7K 0.07% 136
2026
Q1
$979K Sell
7,021
-4
-0.1% -$560 0.1% 108
2025
Q4
$862K Buy
7,025
+21
+0.3% +$2.55K 0.09% 113
2025
Q3
$777K Buy
7,004
+17
+0.2% +$1.93K 0.08% 121
2025
Q2
$775K Buy
6,987
+100
+1% +$10.6K 0.09% 123
2025
Q1
$772K Buy
6,887
+927
+16% +$95.7K 0.11% 104
2024
Q4
$551K Sell
5,960
-163
-3% -$14.7K 0.08% 127
2024
Q3
$513K Sell
6,123
-305
-5% -$23.3K 0.09% 124
2024
Q2
$441K Sell
6,428
-259
-4% -$17.3K 0.08% 127
2024
Q1
$490K Sell
6,687
-414
-6% -$31.8K 0.09% 116
2023
Q4
$575K Buy
7,101
+111
+2% +$8.64K 0.12% 103
2023
Q3
$524K Buy
6,990
+562
+9% +$43.2K 0.13% 103
2023
Q2
$495K Sell
6,428
-254
-4% -$20.3K 0.11% 130
2023
Q1
$554K Buy
6,682
+173
+3% +$14.3K 0.17% 88
2022
Q4
$559K Sell
6,509
-61
-0.9% -$4.83K 0.18% 87
2022
Q3
$405K Buy
6,570
+44
+0.7% +$2.77K 0.15% 91
2022
Q2
$403K Sell
6,526
-1,887
-22% -$117K 0.15% 94
2022
Q1
$500K Sell
8,413
-229
-3% -$14.6K 0.17% 85
2021
Q4
$627K Buy
8,642
+11
+0.1% +$758 0.21% 86
2021
Q3
$603K Sell
8,631
-282
-3% -$19.8K 0.23% 83
2021
Q2
$613K Sell
8,913
-1,585
-15% -$106K 0.24% 78
2021
Q1
$680K Sell
10,498
-750
-7% -$48.4K 0.35% 68
2020
Q4
$655K Sell
11,248
-2,701
-19% -$163K 0.39% 63
2020
Q3
$880K Sell
13,949
-110
-0.8% -$7.63K 0.65% 45
2020
Q2
$1.08M Buy
14,059
+695
+5% +$53.3K 0.79% 39
2020
Q1
$999K Buy
13,364
+1,087
+9% +$75.1K 0.95% 33
2019
Q4
$804K Buy
+12,277
New +$799K 0.72% 45

Other funds holding GILD

Red Door Wealth Management's GILD Position: Q2 2026 in Review

Red Door Wealth Management reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $99.7K and leaving 6,264 shares worth $791K. The position accounts for 0.07% of the portfolio, ranked #136.

Red Door Wealth Management first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.08M in Q2 2020. 352 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Red Door Wealth Management held 6,264 shares of Gilead Sciences worth $791K as of Q2 2026.
  • Red Door Wealth Management sold 757 Gilead Sciences shares in Q2 2026, an estimated $99.7K.
  • Gilead Sciences made up 0.07% of Red Door Wealth Management's portfolio in Q2 2026, its #136 holding.
  • Red Door Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Red Door Wealth Management's Gilead Sciences position peaked at $1.08M in Q2 2020.
  • 352 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.